• Home
  • Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic.

Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic.

Author List
Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT
Publication
JAMA oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/341821698
Publication Year
2022
PubMed ID
36301577
Publication Title
Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT. Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic. JAMA Oncol. 2022 12 01; 8(12):1849-1851.